Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Exxon Mobil | INDUSTRY |
| Makerere University | OTHER |
| Uganda Malaria Surveillance Project | OTHER |
| National Institutes of Health (NIH) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Malaria remains one of the most devastating infectious diseases in the world. Despite the potential for serious adverse outcomes with each episode of malaria, most cases in endemic areas are diagnosed on clinical grounds alone. Even the simple technique of light microscopy, the gold standard for malaria diagnosis, is inaccessible to most individuals in resource-poor malarious areas. New diagnostic methods that are practical for limited health-care settings are urgently needed. Immunochromatographic rapid diagnostic tests (RDTs) for malaria are easy to use, require little infrastructure or expertise, show good accuracy, and are increasingly advocated for routine use in malaria-endemic areas. A major challenge now is to implement RDTs effectively in typical African clinical settings. We plan to evaluate the clinical effectiveness and safety of a training curriculum incorporating RDT use in peripheral government health centers in Uganda. Results from this study will provide evidence for scale-up of RDT implementation in Uganda, as planned by the Uganda Ministry of Health from mid-2008, as well as in other sub-Saharan African countries.
The aim of this study is to evaluate the clinical effectiveness and safety of a basic training program incorporating RDTs, as compared with standard-of-care presumptive treatment, for the management of patients who present with suspected malaria at peripheral health centers in Uganda. Our hypothesis is that training in fever case management and RDT use will allow health center staff to reduce unnecessary antimalarial prescriptions without compromising patient outcomes, compared with the current practice of presumptive antimalarial therapy for all febrile patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | Health centers continue with standard-of-care empiric case management | |
| RDT training | Experimental | Health centers randomly selected to receive training and RDTs, for use in routine patient case management |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| training in use of rapid diagnostic tests (RDTs) for malaria | Device | training program and introduction of RDTs for use in case management of patients presenting for routine care at government health centers |
| Measure | Description | Time Frame |
|---|---|---|
| To compare changes in the proportion of patients prescribed any antimalarial therapy between health centers with and without an RDT training intervention. | point of care |
| Measure | Description | Time Frame |
|---|---|---|
| To compare changes in the proportion of patients with an inadequate response to initial therapy between health centers with and without an RDT training intervention. | 5 days after initial clinic visit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Heidi Hopkins, MD | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uganda Malaria Surveillance Project | Kampala | Uganda |
Not provided
| Label | URL |
|---|---|
| research collaboration website | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D008288 | Malaria |
| D005334 | Fever |
| D004194 | Disease |
| ID | Term |
|---|---|
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D007239 | Infections |
| D000096724 | Mosquito-Borne Diseases |
Not provided
Not provided
| NIH |
| Doris Duke Charitable Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
| D000079426 |
| Vector Borne Diseases |
| D001832 | Body Temperature Changes |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010335 | Pathologic Processes |